Patents Assigned to Progenies Pharmacenticals, Inc.
  • Patent number: 11564621
    Abstract: Presented herein are systems and methods that provide for automated analysis of medical images to determine a predicted disease status (e.g., prostate cancer status) and/or a value corresponding to predicted risk of the disease status for a subject. The approaches described herein leverage artificial intelligence (AI) to analyze intensities of voxels in a functional image, such as a PET image, and determine a risk and/or likelihood that a subject's disease, e.g., cancer, is aggressive. The approaches described herein can provide predictions of whether a subject that presents a localized disease has and/or will develop aggressive disease, such as metastatic cancer. These predictions are generated in a fully automated fashion and can be used alone, or in combination with other cancer diagnostic metrics (e.g., to corroborate predictions and assessments or highlight potential errors). As such, they represent a valuable tool in support of improved cancer diagnosis and treatment.
    Type: Grant
    Filed: January 6, 2020
    Date of Patent: January 31, 2023
    Assignees: Progenies Pharmacenticals, Inc., EXINI Diagnostics AB
    Inventors: Aseem Undvall Anand, Karl Vilhelm Sjöstrand, Jens Filip Andreas Richter